Staidson(Beijing) Biopharmaceuticals Co.,Ltd. Posted 24.4 Million Yuan Net Loss in First Quarter of 2022

Staidson(Beijing) Biopharmaceuticals Co.,Ltd. (舒泰神(北京)生物制药股份有限公司) (300204.SZ) reported a net loss of 24.4 million yuan in the first quarter of 2022, widening 22.6% year-on-year.

Meanwhile, the company posted 123.3 million yuan in revenue, up 6.8% year-on-year.

At the end of the reporting period, it had 1.7 billion yuan in total assets and 259.5 million yuan in total liabilities, with a liability-to-asset ratio of 14.9%.